Outlook Therapeutics (41O.F) Q3 2024 Earnings

14AugConfirmed
Q2 2024
Q3 2024
-1.42
-1.2
-0.98
-0.75

Details

Expected EPS
-0.937834156
Actual EPS
-0.75364
Surprise EPS
0.18
Surprise Percent
+19.64%

Description

Outlook Therapeutics (41O.F) has reported earnings of -0.75364 per share for Q3 2024.

0 Comments

Share your thoughts